1. Home
  2. VALN vs FLGT Comparison

VALN vs FLGT Comparison

Compare VALN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.85

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$16.43

Market Cap

525.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
FLGT
Founded
2012
2011
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.9M
525.3M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
VALN
FLGT
Price
$5.85
$16.43
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$15.50
$28.33
AVG Volume (30 Days)
69.2K
516.3K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,730,000.00
Revenue This Year
N/A
$10.09
Revenue Next Year
$93.87
$12.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.06
$13.46
52 Week High
$12.25
$31.04

Technical Indicators

Market Signals
Indicator
VALN
FLGT
Relative Strength Index (RSI) 48.72 56.54
Support Level $5.81 $13.91
Resistance Level $6.53 $16.70
Average True Range (ATR) 0.25 0.66
MACD 0.12 0.14
Stochastic Oscillator 53.46 97.48

Price Performance

Historical Comparison
VALN
FLGT

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: